These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23623253)
1. Multidimensional optimization of promising antitumor xanthone derivatives. Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253 [TBL] [Abstract][Full Text] [Related]
2. Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models. Azevedo CM; Afonso CM; Soares JX; Reis S; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Gales L; Pinto MM Eur J Med Chem; 2013 Nov; 69():798-816. PubMed ID: 24113365 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor. Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of new xanthone analogues and their biological activity test--cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study. Woo S; Jung J; Lee C; Kwon Y; Na Y Bioorg Med Chem Lett; 2007 Mar; 17(5):1163-6. PubMed ID: 17194586 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity evaluation of a novel series of xanthone derivatives. Guo N; Liu J; Qin L; Jiang D; You X; Lu K; Teng YO; Yu P J Asian Nat Prod Res; 2015; 17(4):377-83. PubMed ID: 25628155 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents. Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety. Zou Y; Zhao Q; Hu H; Hu L; Yu S; Xu M; Wu Q Arch Pharm Res; 2012 Dec; 35(12):2093-104. PubMed ID: 23263803 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents. Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415 [TBL] [Abstract][Full Text] [Related]
9. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines. Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197 [TBL] [Abstract][Full Text] [Related]
10. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines. Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155 [TBL] [Abstract][Full Text] [Related]
11. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7. Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292 [TBL] [Abstract][Full Text] [Related]
12. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors. Cho HJ; Jung MJ; Kwon Y; Na Y Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231 [TBL] [Abstract][Full Text] [Related]
13. Garcinia xanthones as orally active antitumor agents. Zhang X; Li X; Sun H; Wang X; Zhao L; Gao Y; Liu X; Zhang S; Wang Y; Yang Y; Zeng S; Guo Q; You Q J Med Chem; 2013 Jan; 56(1):276-92. PubMed ID: 23167526 [TBL] [Abstract][Full Text] [Related]
14. Novel natural-product-like caged xanthones with improved druglike properties and in vivo antitumor potency. Wu Y; Hu M; Yang L; Li X; Bian J; Jiang F; Sun H; You Q; Zhang X Bioorg Med Chem Lett; 2015 Jun; 25(12):2584-8. PubMed ID: 25958244 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues. Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors. Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860 [TBL] [Abstract][Full Text] [Related]
17. Cytostatic effect of xanthone-loaded mPEG-b-p(HPMAm-Lac2) micelles towards doxorubicin sensitive and resistant cancer cells. Khonkarn R; Mankhetkorn S; Talelli M; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2012 Jun; 94():266-73. PubMed ID: 22377215 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells. Wu J; Dai J; Zhang Y; Wang J; Huang L; Ding H; Li T; Zhang Y; Mao J; Yu S Drug Des Devel Ther; 2019; 13():4239-4246. PubMed ID: 31853172 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of a new dimeric xanthone derivative: enhancement of G-quadruplex selectivity and telomere damage. Franceschin M; Nocioni D; Biroccio A; Micheli E; Cacchione S; Cingolani C; Venditti A; Zizza P; Bianco A; Altieri A Org Biomol Chem; 2014 Dec; 12(47):9572-82. PubMed ID: 25363232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]